Abbott's XIENCE Stent Ok'd In Europe For Shorter Dual Anti-Platelet Therapy After ImplantBenzinga • 04/06/21
Abbott's XIENCE™ Stent Receives European Approval for One-Month Dual Anti-Platelet Therapy (DAPT) for High Bleeding Risk PatientsPRNewsWire • 04/06/21
Abbott's BinaxNOW™ Rapid Antigen Self Test Receives FDA Emergency Use Authorization for Asymptomatic, Over-the-Counter, Non-Prescription, Multi-Test UsePRNewsWire • 04/01/21
Abbott Announces its Pandemic Defense Coalition: A Global Network of Expert Collaborators Designed To Help Prevent Future Pandemics, Currently Searching for COVID-19 VariantsPRNewsWire • 03/11/21
Abbott's Molecular Assay Gets FDA EUA Approval To Detect SARS-CoV-2 And Flu In One TestBenzinga • 03/05/21
4 Stocks to Watch as FDA Action Plan Stresses MedTech DigitizationZacks Investment Research • 03/05/21
The Pandemic is a Long-Term Factor (NASDAQ: QDEL) (NYSEAMERICAN: APT) (OTC US: BNOW) (NYSE: ABT)OTC PR Wire • 03/04/21